Oakland, United States
Promaxo is a Health Care startup founded in 2016 and headquartered in the United States. The company's slogan, "We are transforming the lives of patients and doctors through our single-sided portable MRI. Fast, safe and convenient," encapsulates its mission to revolutionize healthcare. Promaxo has developed a compact and adaptable MRI system, redefining the standard of care by improving the quality and speed of patient diagnosis and interventions.
In a significant milestone, in March 2021, Promaxo received 510(k) clearance from the U.S. FDA for its revolutionary office-based MRI system, enabling practices and hospitals to seamlessly guide prostate interventions under the single-sided scanner. This breakthrough underscores the company's commitment to innovation and pushing the boundaries of medical technology.
Furthermore, in June 18, 2024, Promaxo secured its most recent funding in a Venture Round, with Zynext Ventures stepping in as the investor. This investment is indicative of the growing interest in Promaxo's disruptive approach to healthcare and highlights the confidence that prominent investors have in the startup's potential.
Promaxo's innovative solutions and recent accomplishments position the company at the forefront of medical technology, offering a promising outlook for both patients and healthcare providers. By addressing the need for fast, safe, and convenient MRI solutions, Promaxo is poised to make a significant impact in the healthcare industry, improving patient care and outcomes.
For more information and inquiries, please reach out to [email protected].
